Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3192 |
|
| Actual shortage: | 254 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2927 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
14 (5%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-PRAZOSIN | 2MG | TABLET | Resolved | 2022-01-27 | 2022-03-24 | 153736 |
| TEVA-PRAZOSIN | 5MG | TABLET | Resolved | 2022-02-10 | 2022-03-24 | 154729 |
| TEVA-PRAZOSIN | 1MG | TABLET | Resolved | 2022-09-22 | 2022-10-01 | 169951 |
| TEVA-PRAZOSIN | 1MG | TABLET | Resolved | 2022-11-14 | 2025-06-20 | 174592 |
| TEVA-PRAZOSIN | 2MG | TABLET | Resolved | 2022-12-01 | 2025-06-20 | 176803 |
| TEVA-PRAZOSIN | 5MG | TABLET | Resolved | 2022-12-01 | 2025-06-20 | 176806 |
| TEVA-PRAZOSIN | 1MG | TABLET | Resolved | 2025-09-11 | 2025-11-13 | 266982 |
| TEVA-PRAZOSIN | 2MG | TABLET | Resolved | 2025-09-18 | 2025-11-13 | 267451 |
| TEVA-PRAZOSIN | 5MG | TABLET | Resolved | 2025-09-18 | 2025-11-27 | 267454 |
| TEVA-PREDNISOLONE | 1% | SUSPENSION | Resolved | 2019-06-18 | 2019-08-06 | 86933 |
| TEVA-PREDNISOLONE | 1% | SUSPENSION | Resolved | 2019-06-18 | 2020-05-01 | 86936 |
| TEVA-PREDNISOLONE | 1% | SUSPENSION | Resolved | 2019-10-17 | 2020-05-21 | 96724 |
| TEVA-PREDNISOLONE | 1% | SUSPENSION | Resolved | 2022-03-31 | 2022-06-17 | 157647 |
| TEVA-PREDNISOLONE | 1% | SUSPENSION | Resolved | 2022-04-28 | 2022-05-26 | 159581 |
| TEVA-PREDNISOLONE | 1% | SUSPENSION | Resolved | 2022-08-18 | 2022-10-01 | 167206 |
| TEVA-PREDNISOLONE | 1% | SUSPENSION | Resolved | 2022-10-17 | 2023-06-09 | 172030 |
| TEVA-PREDNISOLONE | 1% | SUSPENSION | Resolved | 2022-12-15 | 2023-06-09 | 178527 |
| TEVA-PREDNISOLONE | 1% | SUSPENSION | Resolved | 2023-06-20 | 2023-06-27 | 195861 |
| TEVA-PREDNISOLONE | 1% | SUSPENSION | Resolved | 2025-01-09 | 2025-08-14 | 247316 |
| TEVA-PREDNISOLONE | 1% | SUSPENSION | Resolved | 2025-02-20 | 2025-08-14 | 250900 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-VALSARTAN | 40MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258501 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255827 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255830 |
| TEVA-VALSARTAN/HCTZ | 25MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255833 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256140 |
| TEVA-VALSARTAN/HCTZ | 25MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256143 |
| TEVA-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-02-07 | 2020-02-08 | 105537 |
| TEVA-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117546 |
| TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-09-24 | 2020-09-24 | 124899 |
| TEVA-VORICONAZOLE | 200MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256166 |
| TEVA-VORICONAZOLE | 50MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256169 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-09-27 | 2019-10-01 | 94980 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-10-17 | 2019-10-17 | 96695 |
| ZOLEDRONIC ACID FOR INJECTION | 4MG | SOLUTION | Discontinued | 2025-05-28 | 2025-05-28 | 258583 |
| ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |